NTBL: Notable Labs, Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.57
Enterprise Value ($M) -3.09
Book Value ($M) 15.11
Book Value / Share 1.68
Price / Book 0.57
NCAV ($M) 11.04
NCAV / Share 1.22
Price / NCAV 0.78

Profitability (mra)
Return on Invested Capital (ROIC) -0.65
Return on Assets (ROA) -1.73
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.65
Current Ratio 5.65

Balance Sheet (mrq) ($M)
Current Assets 15.47
Assets 19.54
Liabilities 4.43
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.31
Operating Income -14.66
Net Income -11.26

Cash Flow Statement (mra) ($M)
Cash From Operations -13.72
Cash from Investing 15.54
Cash from Financing 7.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-11 13G/A FR Capital Holdings, L.P. 3.02 -73.79
10-26 13G B Capital Fund II, L.P. 11.20
10-19 13D Builders VC Fund I (Canada), L.P. 25.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 7,883 16,772 47.00
2024-05-02 5,884 2,042 288.15
2024-05-01 10,320 4,189 246.36
2024-04-30 1,875 3,987 47.03
2024-04-29 1,958 7,333 26.70

(click for more detail)

Similar Companies
NRBO – NeuroBo Pharmaceuticals, Inc. NRSN – NeuroSense Therapeutics Ltd.
NRXP – NRx Pharmaceuticals, Inc. NVCT – Nuvectis Pharma, Inc.
OCEA – Ocean Biomedical, Inc.


Financial data and stock pages provided by
Fintel.io